Donald Trump Jr. agrees with Mark Cuban on social media over the problem of drug middlemen in American health care.

Drugmakers Pfizer and Flynn Pharma have been ... so they were no longer subject to price regulations. Pfizer hiked the price of the drug between 780% and 1,600%, and also supplied the drug to ...

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He has long wanted to ...

The company’s first product, a palatable anti-parasitic drug, made to taste like ... As a consequence of Pfizer’s innovation, the price of citric acid tumbled over the succeeding decades ...

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He’s long wanted to ...

Health and Human Services Secretary Robert F. Kennedy Jr. wants to make it harder and more expensive for drug companies to advertise to patients.

Pharmaceutical companies are taking advantage of the drug patent system to keep prices of essential medications high, ...

Google Gemini is making waves in 2025 with advanced AI tools built to support entrepreneurs and small business owners. This ...

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...